Landing Med On-premise AI Cervical Cytology System — 10M+ Samples Trained

Landing Med provides AI-powered cervical cancer screening solutions using computer vision analysis of cytological pathology images combined with cloud and edge computing for real-time diagnostic support. The platform has enabled over 12 million cumulative screenings and supports a remote pathology network covering 91% of underserved and remote areas in China. The AI system analyzes cell samples to identify precancerous lesions and cervical cancer indicators, providing screening results in near-real-time to rural and remote medical institutions that lack specialized pathologists.